APA Annual Meeting 2025
NeuroKaire exhibited at the American Psychiatric Association Annual Meeting in Los Angeles from May 17–21, 2025. At Booth #1140, we presented how our platform brings AI and patient-derived neurons into clinical practice to personalize treatment for depression
NeuroKaire participated in the 2025 APA Annual Meeting, held May 17–21 in Los Angeles—the premier event in psychiatry, with over 450 sessions, 50+ topics, and more than 8 educational tracks.
At Booth #1140, our team connected with psychiatrists, researchers, and healthcare innovators to showcase how our platform is translating cutting-edge science into real-world clinical practice. Using a simple blood test, NeuroKaire harnesses patient-derived neurons and advanced AI to personalize depression treatment—supporting clinicians in making more effective, data-driven decisions.
Whether attendees were exploring the latest in neuroscience or looking for ways to advance personalized care, our presence at APA was a great opportunity to exchange ideas, share breakthroughs, and explore how precision psychiatry can transform mental health outcomes.
Highlights:
- Booth #1140: Demos and live discussions with the NeuroKaire team
- AI-driven personalization of depression treatment
- Patient-derived neuron technology explained
- Connecting with clinicians, scientists, and decision-makers across psychiatry
Schedule a Meet & Greet
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel